LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern

Autor: Lin Lin Ren, Yu Jie Bao, Jing-Yuan Fang, Tingting Yan, Weiping Zou, Jie He, Yanwei Lin, Jiayin Tang, Ta Chung Yu, Ying Xuan Chen, Danfeng Sun, Tian-Tian Sun, Haoyan Chen, Jie Hong, Ye Hu, Qian Liang
Rok vydání: 2015
Předmět:
0301 basic medicine
Male
Chromatin Immunoprecipitation
medicine.disease_cause
Bioinformatics
Models
Biological

Metastasis
Epigenesis
Genetic

Histones
03 medical and health sciences
Mice
0302 clinical medicine
Stomach Neoplasms
Cell Line
Tumor

medicine
WDR5
Animals
Cluster Analysis
Humans
Gene Regulatory Networks
Histone methyltransferase complex
Histone Acetyltransferases
biology
Superoxide Dismutase
Gene Expression Profiling
Intracellular Signaling Peptides and Proteins
Computational Biology
High-Throughput Nucleotide Sequencing
Histone acetyltransferase
Histone-Lysine N-Methyltransferase
medicine.disease
Tumor Burden
Gene expression profiling
Disease Models
Animal

030104 developmental biology
Histone
Cell Transformation
Neoplastic

Oncology
030220 oncology & carcinogenesis
biology.protein
Cancer research
Disease Progression
Heterografts
RNA
Long Noncoding

Carcinogenesis
Chromatin immunoprecipitation
Protein Binding
Zdroj: Cancer discovery. 6(7)
ISSN: 2159-8290
Popis: Long noncoding RNAs (lncRNA) play a role in carcinogenesis. However, the function of lncRNAs in human gastric cancer remains largely unknown. In this study, we identified a novel lncRNA, GClnc1, which was upregulated and associated with tumorigenesis, tumor size, metastasis, and poor prognosis in gastric cancer. GClnc1 affected gastric cancer cell proliferation, invasiveness, and metastasis in multiple gastric cancer models. Mechanistically, GClnc1 bound WDR5 (a key component of histone methyltransferase complex) and KAT2A histone acetyltransferase, acted as a modular scaffold of WDR5 and KAT2A complexes, coordinated their localization, specified the histone modification pattern on the target genes, including SOD2, and consequently altered gastric cancer cell biology. Thus, GClnc1 is mechanistically, functionally, and clinically oncogenic in gastric cancer. Targeting GClnc1 and its pathway may be meaningful for treating patients with gastric cancer. Significance: This report documents a novel lncRNA, GClnc1, which may act as a scaffold to recruit the WDR5 and KAT2A complex and modify the transcription of target genes. This study reveals that GClnc1 is an oncogenic lncRNA in human gastric cancer. Cancer Discov; 6(7); 784–801. ©2016 AACR. This article is highlighted in the In This Issue feature, p. 681
Databáze: OpenAIRE